# Immunity to Infection in Healthy Participants and Participants With Cancer

> **NCT05787964** · — · UNKNOWN · sponsor: **University Hospital Tuebingen** · enrollment: 200 (estimated)

## Conditions studied

- Influenza
- SARS-CoV-2
- Hematologic Malignancy
- Solid Tumor

## Interventions

- **PROCEDURE:** Biological sample collection

## Key facts

- **NCT ID:** NCT05787964
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05787964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05787964, "Immunity to Infection in Healthy Participants and Participants With Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05787964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*